Company news

GlucoTrack, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

February 24, 2025

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

February 3, 2025

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

February 3, 2025

Glucotrack Announces Reverse Stock Split

January 29, 2025

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

January 28, 2025

Glucotrack Announces ISO 13485: 2016 Certification

January 20, 2025

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

January 14, 2025

Glucotrack to Present at TechBio Showcase™ 2025

January 6, 2025

Advancing Clinical Studies, Meeting Regulatory Milestones, Strengthening Its Strategic Framework And More: The Past Year For Glucotrack, And What Lies Ahead

January 6, 2025

Driving Innovation In Diabetes Management: Glucotrack Begins Enrollment For Human Clinical Trials For Its Implantable Continuous Blood Glucose Monitor

December 4, 2024

GlucoTrack announces start of enrollment for human clinical study of continuous blood glucose monitor

December 2, 2024

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

November 13, 2024

Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering

November 12, 2024

GlucoTrack to present at 2024 BioFuture conference

October 21, 2024

Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology

October 3, 2024

GlucoTrack announces oral & poster presentations at the 2024 diabetes technology meeting

September 30, 2024

John Ballantyne, former biotechnology executive, joins the glucotrack board of directors

September 2, 2024

GlucoTrack announces new Vice President of clinical operations

August 26, 2024

Poster Presentations, Upcoming Human Trials, Recently Secured Funding And More: Glucotrack’s Plans To Transform The Continuous Glucose Monitoring Market

August 25, 2024

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

August 20, 2024

Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

August 14, 2024

GlucoTrack announces poster presentation on continuous blood glucose monitor survey data at the association of diabetes care and education specialists (ADCES) 2024 annual conference

August 4, 2024

GlucoTrack announces new funding for development of its continuous blood glucose monitor

July 30, 2024

GlucoTrack announces the appointment of Andy Balo to board of directors

June 19, 2024

GlucoTrack reports successful completion of first reported long-term preclinical study of its epidural glucose monitoring sensor

June 12, 2024

GlucoTrack to present in the June 2024 sidoti small cap conference

June 9, 2024

GlucoTrack announces 90-day preclinical study results that demonstrate sustained accuracy of its implantable continuous blood glucose monitor

June 4, 2024

GlucoTrack’s epidural glucose monitoring sensor demonstrates successful 30-day safety & performance in long-term preclinical study

May 15, 2024

GlucoTrack announces reverse stock split

May 14, 2024

GlucoTrack announces abstracts accepted for poster presentation at 84th scientific sessions of the american diabetes association

May 1, 2024

GlucoTrack announces closing of private placement

April 21, 2024

GlucoTrack announces expansion of its continuous glucose monitoring technology to epidural glucose monitoring

April 15, 2024

GlucoTrack announces increased sensor longevity for its implantable continuous blood glucose monitor

April 1, 2024

GlucoTrack expands leadership team with new vice president of Quality

March 11, 2024

GlucoTrack selects Cirtec Medical as manufacturer for its implantable continuous blood glucose monitor

February 26, 2024

GlucoTrack announces the appointment of Luis Malavé to chair of the board of directors

February 12, 2024

GlucoTrack announces early accuracy data for its implantable continuous glucose monitor

January 1, 2024

GlucoTrack announces 180-day extension to regain compliance with NASDAQ minimum bid price requirement

November 29, 2023

GlucoTrack announces shareholder update

November 12, 2023

GlucoTrack announces preclinical testing with implantable continuous glucose monitor

October 11, 2023

GlucoTrack announces the appointment of Erin Carter to board of directors

August 30, 2023

GlucoTrack announces new VP of marketing

August 27, 2023

GlucoTrack announces positive data from feasibility study for implantable continuous glucose monitor

July 24, 2023

GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock

April 16, 2023

GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock

April 12, 2023

GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock

April 11, 2023

GlucoTrack provides shareholder update

March 13, 2023

GlucoTrack announces the hiring of Dr. Mark Tapsak

October 13, 2022

GlucoTrack to begin research & development of novel continuous glucose monitoring system

October 9, 2022

GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor

June 21, 2022

← Newer news releases · Older news releases →

Decks

The 5 newest of 11 decks. Every deck is listed under its year.